ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2016

Abstract Number: 237

Characterization of Peripheral Lymphocyte Phenotype in Patients with IgG4-Related Disease

Satoshi Kubo1, Shingo Nakayamada2, Maiko Yoshikawa1, Yusuke Miyazaki1, Jidong Zhao1, Ippei Miyagawa3, Shigeru Iwata4, Shintaro Hirata1, Kazuhisa Nakano3, Kazuyoshi Saito3 and Yoshiya Tanaka5, 1The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 2First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 3University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 4First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 5University of Occupational and Environmental Health, Kitakyushu, Japan

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2016

Date of first publication: September 28, 2016

Keywords: IgG4 Related Disease and flow cytometry

Session Information

Date: Sunday, November 13, 2016

Title: Miscellaneous Rheumatic and Inflammatory Diseases - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

IgG4 related disease (IgG4-RD) is a systemic disease that is characterized by the infiltration of IgG4secreting plasma cells and effector T cells into various organs. However, the characteristics and pathological role of immune cell subsets remain unclear. The aim of this study was to investigate the characteristic phenotype of immune cell subsets in IgG4-RD.

Methods:

Peripheral blood mononuclear cells were obtained from 16 patients with IgG4-RD, 4 with primary Sjogren syndrome (pSS) and 23 healthy donors (HD). The phenotype of circulating B cells, T cells were defined based on comprehensive flow cytometric analysis for human immune system termed ‘the Human Immunology Project’ by NIH/FOCIS. CD4+Bcl-6+ T follicular helper (Tfh) cells were detected by immunohistochemistry in salivary glands obtained by the biopsy.

Results:

Baseline characteristics of patients with IgG4-RD were (means); age 60 years old, symptom duration 19 months, serum IgG 2735 mg/dl, IgG4 694 mg/dl, CRP 0.7 mg/dl. The proportions of CD3+CD4+CD45RA–CCR7– effector memory T cells, CD3+CD4+CD45RA+CCR7– effector T helper cells increased, whereas naive T cells decreased in IgG4-RD, compared to HD and pSS. There was no difference in the proportion of well known helper T cell subsets (Th1, Th17, and Treg) between IgG4-RD, pSS and HD. On the other hand, the proportions of CD4+CXCR5+ICOS+ Tfh and CD19+CD20–CD27+CD38+ plasmablasts were significant higher in IgG4-RD, compared to pSS and HD. Moreover, the proportion of Tfh in peripheral blood tended to be higher in patients whose Tfh more densely accumulated in the salivary gland. Among multiple immune cell subsets, the proportion of Tfh and that of plasmablasts were positively correlated, revealing statistical clustering. Of note, the percentage of plasmablasts was correlated with serum IgG levels. Furthermore, the proportion of plasmablasts and that of Tfh were higher in patients with extra glandular manifestations, compared to patients without them. After treatment with glucocorticoids, the proportion of plasmablasts and that of Tfh decreased with the improvement of clinical manifestations.

Conclusion: These results revealed that the higher proportion of Tfh cells and plasmablasts is characteristically observed in IgG4-RD. The frequency of Tfh was correlated with that of plasmablasts, and the Tfh/plasmablast axis contributed to organ manifestation of IgG4-RD. Our findings would clarify the pathogenesis of IgG4-RD through the interaction between Tfh cells and plasmablasts and suggest a potential as the therapeutic target of this disease.


Disclosure: S. Kubo, Bristol-Myers Squibb, 5; S. Nakayamada, None; M. Yoshikawa, None; Y. Miyazaki, None; J. Zhao, None; I. Miyagawa, None; S. Iwata, None; S. Hirata, None; K. Nakano, None; K. Saito, None; Y. Tanaka, Bristol-Myers Squibb, MSD, Chugai, Mitsubishi-Tanabe, Astellas, AbbVie, Daiichi-Sankyo, 2,UCB Pharma, Mitsubishi-Tanabe, Abbott, AbbVie, Eisai, Chugai, Janssen, Pfizer, Takeda, Astellas, Daiichi-Sankyo, GlaxoSmithKline, AstraZeneca, Eli Lilly, Quintiles, MSD, Asahi Kasei, 5.

To cite this abstract in AMA style:

Kubo S, Nakayamada S, Yoshikawa M, Miyazaki Y, Zhao J, Miyagawa I, Iwata S, Hirata S, Nakano K, Saito K, Tanaka Y. Characterization of Peripheral Lymphocyte Phenotype in Patients with IgG4-Related Disease [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/characterization-of-peripheral-lymphocyte-phenotype-in-patients-with-igg4-related-disease/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterization-of-peripheral-lymphocyte-phenotype-in-patients-with-igg4-related-disease/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology